Blinding and expectancy confounds in psychedelic randomized controlled trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blinding and expectancy confounds in psychedelic randomized controlled trials
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 14, Issue 9, Pages 1133-1152
Publisher
Informa UK Limited
Online
2021-05-27
DOI
10.1080/17512433.2021.1933434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
- (2021) L. S. Kaertner et al. Scientific Reports
- Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
- (2020) Dawn F Ionescu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
- (2019) Samuel T. Wilkinson et al. NEUROPSYCHOPHARMACOLOGY
- Not Just Nonspecific Factors: The Roles of Alliance and Expectancy in Treatment, and Their Neurobiological Underpinnings
- (2019) Sigal Zilcha-Mano et al. Frontiers in Behavioral Neuroscience
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Meta-Analysis of Placebo Response in Adult Antidepressant Trials
- (2019) Fenghua Li et al. CNS DRUGS
- Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial
- (2019) Yoav Domany et al. DEPRESSION AND ANXIETY
- The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
- (2019) David S. Mathai et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study
- (2018) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Psychedelics and the essential importance of context
- (2018) Robin L Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Understanding and misunderstanding randomized controlled trials
- (2018) Angus Deaton et al. SOCIAL SCIENCE & MEDICINE
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Science in flux: Registered reports and beyond at the European Journal of Neuroscience
- (2018) Christopher D. Chambers et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG
- (2018) Zehong Cao et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Equipoise in Research
- (2017) Alex John London JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
- (2017) Sarah Ballou et al. Trials
- LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation
- (2017) Rainer Kraehenmann et al. Frontiers in Pharmacology
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
- (2016) Darragh Downey et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study
- (2016) Cheng-Ta Li et al. HUMAN BRAIN MAPPING
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
- (2016) Rafael Faria Sanches et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
- (2016) Ido Hartogsohn JOURNAL OF PSYCHOPHARMACOLOGY
- A Double-Blinded, Randomized, Placebo-Controlled Sub-Dissociative Dose Ketamine Pilot Study in the Treatment of Acute Depression and Suicidality in a Military Emergency Department Setting
- (2016) John Burger et al. MILITARY MEDICINE
- The Emergence of the Randomized, Controlled Trial
- (2016) Laura E. Bothwell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
- (2015) Y.-D. Hu et al. PSYCHOLOGICAL MEDICINE
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
- (2015) Flávia de L. Osório et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
- (2014) J Savović et al. HEALTH TECHNOLOGY ASSESSMENT
- Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies
- (2014) Asbjørn Hróbjartsson et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Placebo Effects: From the Neurobiological Paradigm to Translational Implications
- (2014) Fabrizio Benedetti NEURON
- Pilot dose–response trial of i.v. ketamine in treatment-resistant depression
- (2014) Rosalyn Lai et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Clinic Visits in Late-Life Depression Trials: Effects on Signal Detection and Therapeutic Outcome
- (2013) Bret R. Rutherford et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- A Model of Placebo Response in Antidepressant Clinical Trials
- (2013) Bret R. Rutherford et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Schedule I drug laws on neuroscience research and treatment innovation
- (2013) David J. Nutt et al. NATURE REVIEWS NEUROSCIENCE
- Development of the Stanford Expectations of Treatment Scale (SETS): A tool for measuring patient outcome expectancy in clinical trials
- (2012) Jarred Younger et al. Clinical Trials
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- (2012) Teri S Krebs et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A randomized, prospective pilot study of patient expectancy and antidepressant outcome
- (2012) B. R. Rutherford et al. PSYCHOLOGICAL MEDICINE
- Accounting for perception, placebo and unmasking effects in estimating treatment effects in randomised clinical trials
- (2011) Farid Jamshidian et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta-epidemiologic study
- (2009) Eveline Nüesch et al. ARTHRITIS AND RHEUMATISM
- Towards a proposal for assessment of blinding success in clinical trials: up-to-date review
- (2009) Jafar Kolahi et al. COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY
- Does Study Design Influence Outcome?
- (2009) Bret R. Rutherford et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Glutamate and the Neural Basis of the Subjective Effects of Ketamine
- (2008) J. F. William Deakin et al. ARCHIVES OF GENERAL PSYCHIATRY
- Do “placebo responders” exist?
- (2008) Ted J. Kaptchuk et al. Contemporary Clinical Trials
- Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
- (2008) George I. Papakostas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
- (2008) Ted J Kaptchuk et al. BMJ-British Medical Journal
- Confounding: What it is and how to deal with it
- (2007) K.J. Jager et al. KIDNEY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search